AIDS and malignancy: experience of an inner city primary care hospital (Meeting abstract). NLM AIDSLINE Important note: Information in this article was accurate in 1993. The state of the art may have changed since the publication date.

Click here to return to AIDSLINE main menu
DonateNow
Print this Article


AIDS and malignancy: experience of an inner city primary care hospital (Meeting abstract).

Proc Annu Meet Am Soc Clin Oncol; 12:A22 1993. Unique Identifier : AIDSLINE ICDB/93694422
Savona S; Ohri A; Lakkis W; Salloum E; Garcia N; Hewlett D; Lincoln Hosp., Bronx, NY 10451

Abstract: Lincoln Hospital is a primary care institution in the South Bronx where the in-hospital HIV rate is estimated at 10%. The major risk factors for HIV infection are iv drug use in 70%, heterosexual contact in 20%, homosexual contact in 5% and blood product associated in 5%. The HIV registry consists of patients (pts) since 1988 of which 50% have expired. CDC criteria for AIDS were met in 890 pts. There have been 46 cases of malignancy in AIDS. Data are presented in a table. Only 8 pts with Kaposi's sarcoma and 4 pts with lymphoma had been on antiviral drugs for 3 mo prior to a diagnosis of malignancy. Metastatic disease was noted in 100% of lung, breast and testicular pts, 75% of cervical pts and 50% of colon pts. High-grade lymphoma was seen in 80% of lymphoma cases. Kaposi's sarcoma presented with mucus membrane or parenchymal involvement in 20% of the cases. The median survival from the diagnosis of cancer with AIDS was 12 mo. The incidence of cancer in our population for HIV infection is 1.7% and for AIDS is 5.2%.
Keywords: Acquired Immunodeficiency Syndrome/*EPIDEMIOLOGY/MORTALITY Cross-Sectional Studies Human Incidence Lymphoma, AIDS-Related/EPIDEMIOLOGY/MORTALITY Neoplasms/*EPIDEMIOLOGY/MORTALITY New York City/EPIDEMIOLOGY Registries/STATISTICS & NUMER DATA Sarcoma, Kaposi's/EPIDEMIOLOGY/MORTALITY Skin Neoplasms/EPIDEMIOLOGY/MORTALITY Survival Rate Urban Population/*STATISTICS & NUMER DATA ABSTRACTKWDacquiredimmunodeficiencysyndrome/KWDepidemiology/mortalitycross-sectionalstudieshumanincidencelymphoma,aids-related/epidemiology/mortalityneoplasms/KWDepidemiology/mortalitynewyorkcity/epidemiologyregistries/statistics&numerdatasarcoma,kaposi's/epidemiology/mortalityskinneoplasms/epidemiology/mortalitysurvivalrateurbanpopulation/KWDstatistics&numerdataabstract
931230
M93C0809

Copyright © 1993 - National Library of Medicine. Reproduced under license with the National Library of Medicine, Bethesda, MD.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Bristol-Myers Squibb Company, Elton John AIDS Foundation, Gill Foundation, the National Library of Medicine, Quest Diagnostics, Roche and Trimeris, and donations from users like you. Always watch for outdated information. This article first appeared in 1993. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1993. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content. .